查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2002639

家用透析系統市場：依治療方法、設備類型、最終用戶和分銷管道分類－2026-2032年全球市場預測

Home Dialysis Systems Market by Modality, Device Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，家用透析系統市場價值將達到 272.5 億美元，到 2026 年將成長至 302 億美元，到 2032 年將達到 562.8 億美元，年複合成長率為 10.91%。

主要市場統計數據
基準年 2025 272.5億美元
預計年份：2026年 302億美元
預測年份 2032 562.8億美元
複合年成長率 (%) 10.91%

以患者為中心的創新、臨床實踐的改變以及營運模式的重新設計將如何改變家庭透析護理的提供方式，展望未來前景。

腎臟護理的發展趨勢日益顯著，其驅動力在於從以機構為中心的強化護理模式轉向以患者為中心的居家治療模式，後者更加重視便利性、臨床療效和生活品質。設備人體工學、耗材設計、遠端監測和臨床通訊協定的進步降低了居家透析的傳統門檻，使更多患者和醫療服務提供者能夠將居家血液透析和腹膜透析視為可行的長期照護策略。在此背景下，臨床、營運和商業領域的相關人員需要重新定義他們對市場的理解，不再將其視為以機構為中心的傳統模式，而是將其視為以分散式照護路徑為特徵的模式。

科技進步、保險公司的支持趨勢以及病人偏好的改變是如何共同將家庭透析轉變為去中心化、數位化驅動的照護模式的？

近年來，科技、監管和行為趨勢的共同作用，為居家透析環境帶來了變革性的改變。遠端醫療和遠距監測已從小眾先導計畫發展成為居家透析計畫的核心要素，使臨床醫生能夠在患者居家期間持續進行臨床監督。同時，設備製造商優先考慮提高設備的便攜性、簡化安裝流程和實現自動化安全檢查，使更多患者能夠享受居家透析服務。這些設計上的進步也得益於耗材和透析液管理方面的改進，從而減輕了實體儲存負擔並簡化了更換流程。

評估 2025 年關稅變化將如何促使供應鏈重組、加速本地採購以及改變產品設計，以確保醫療保健的連續性。

2025年關稅措施的實施立即引起了人們對整個全球醫療設備供應鏈的關注，其中包括家用透析系統使用的組件和耗材。對進口原料、成品和專用耗材徵收的關稅迫使採購團隊重新評估其籌資策略和供應商組合。為此，許多相關人員加快了近岸外包的步伐，實現了供應商基礎的多元化，並加強了對替代供應商的審查，以降低單一來源依賴的風險並減少前置作業時間的波動。這些供應鏈策略調整使採購重點從追求最低成本轉向優先考慮供應商的韌性和品質的持續性。

將治療方法方案、醫療設備類型、通路和最終用戶畫像與投資和商業化要求聯繫起來的細分市場主導洞察。

將居家透析市場進行詳細細分，可清楚展現臨床價值與商業性機會的交會點。依透析方式分類，市場分為家庭血液透析及居家腹膜透析。家庭血液透析又細分為常規血液透析、夜間血液透析和短時日間血液透析；而腹膜透析則細分為自動化腹膜透析和連續性移動腹膜透析。每種治療方法及其子類別都有其獨特的臨床工作流程、患者培訓要求和設備功能優先級，這些因素都會影響其應用趨勢和支持模式。例如，設備的可靠性和隱蔽性對於夜間或過夜治療至關重要，而快速設置和減輕看護者負擔則是短時日間治療的優先考慮因素。

區域趨勢和營運實際情況決定了世界主要地區的差異化部署管道和特定區域的商業化策略。

區域趨勢正在影響居家透析的普及軌跡和營運模式。在美洲，臨床實務指引、報銷政策和病患支持活動促成了居家透析普及的集中區域。同時，醫療保健系統的整合和對數位醫療的投資正在推動業務擴張。此外，該地區的物流網路和經銷夥伴關係強調整合服務和基於價值的契約，這影響著設備和耗材的捆綁銷售和報銷方式。

競爭定位分析重點闡述了成熟企業、專業供應商和數位新興企業如何透過整合臨床和服務能力來重塑其價值提案。

家用透析領域的競爭動態複雜多樣，既有傳統的醫療設備製造商，也有專業的耗材供應商，還有專注於軟體驅動型護理的數位化新興參與企業。現有醫療設備製造商在監管合規經驗、臨床證據累積和成熟的分銷網路方面保持優勢，這些優勢支撐著他們建立的大規模採購關係。而新興參與企業則往往透過更簡潔的設計、創新的耗材以及整合的遠端監測功能來吸引以患者為中心的醫療項目，從而脫穎而出。

為行業領導者提供可操作的策略性舉措，以簡化患者流程、加強供應鏈並整合數位化醫療服務，從而擴大家庭透析項目

產業領導者應優先考慮一系列切實可行的舉措，以在不斷發展的居家透析生態系統中獲取價值。首先，投資於能夠簡化患者工作流程並最大限度減少耗材處理的產品設計，從而降低患者自我用藥的門檻並提高用藥依從性。其次，透過建構遠端監測、預測性維護和護理協調能力來加速數位化整合，從而減輕醫療專業人員的負擔並實現基於結果的合約。第三，透過區域供應商認證、推廣組件模組化以及探索本地組裝方案來實現供應鏈多元化並降低風險，從而即使在貿易中斷期間也能維持護理的連續性。

調查方法結合了相關人員訪談、臨床文獻整合和供應鏈分析，為家庭透析系統提供了檢驗且可操作的見解。

本分析的調查方法透過交叉引用與關鍵相關人員的訪談、醫療設備和臨床文獻綜述、監管分析以及供應鏈圖譜，對家庭透析系統進行了綜合觀點。研究人員對臨床醫生、供應鏈經理和銷售主管進行了初步訪談，以確定營運限制、推廣促進因素和尚未解決的需求。除了這些定性研究結果外，研究人員還對醫療設備設計趨勢、耗材創新和已發表的臨床通訊協定進行了系統性回顧，以確保技術的準確性和相關性。

為了促進永續家庭透析的廣泛應用，我們正在整合關鍵策略挑戰，以協調設備創新、臨床支援和供應鏈韌性。

總之，居家透析正處於轉折點，臨床進步、病患偏好和營運模式的重新設計共同為持續改善醫療服務創造了機會。居家照護的轉型需要整合解決方案，這些方案應結合設備創新和培訓、可靠的供應鏈以及與保險公司的合作。儘管貿易趨勢和區域差異需要採取不同的策略，但以患者為中心、數位化驅動的護理這一基本趨勢在各地區保持一致。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：家用透析系統市場：依透析方式分類

  • 居家血液透析
    • 傳統血液透析
    • 夜間血液透析
    • 短期門診血液透析
  • 腹膜透析
    • 自動腹膜透析
    • 持續性移動腹膜透析

第9章 家用透析系統市場：依設備類型分類

  • 配件
  • 消耗品
    • 透析濃縮液
    • 篩選
  • 裝置

第10章 家用透析系統市場：依最終用戶分類

  • 居家醫療服務提供者
  • 自我管理

第11章：家用透析系統市場：依分銷管道分類

  • 線上
  • 零售

第12章 家用透析系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 家用透析系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 家用透析系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國家用透析系統市場

第16章：中國家用透析系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allmed Medical Care Holdings Limited
  • AWAK Technologies Pte. Ltd.
  • B. Braun Avitum AG
  • Bain Medical Equipment Co., Ltd.
  • Baxter International Inc.
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Jiangsu Jihua Medical Instruments Co., Ltd.
  • JMS Co., Ltd.
  • Kawasaki Laboratories, Inc.
  • Medica SpA
  • Medical Components, Inc.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Ltd.
  • Rockwell Medical, Inc.
  • SWS Hemodialysis Care
  • Toray Medical Co., Ltd.
  • Weigao Group
Product Code: MRR-0D217D5ADC94

The Home Dialysis Systems Market was valued at USD 27.25 billion in 2025 and is projected to grow to USD 30.20 billion in 2026, with a CAGR of 10.91%, reaching USD 56.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.25 billion
Estimated Year [2026] USD 30.20 billion
Forecast Year [2032] USD 56.28 billion
CAGR (%) 10.91%

A forward-looking overview of how patient-centered innovation, clinical practice shifts, and operational redesign are reshaping home dialysis care delivery

The evolution of renal care is increasingly anchored by a shift from centralized in-center treatment toward patient-centered home therapy that emphasizes convenience, clinical outcomes, and quality of life. Advances in device ergonomics, consumable design, remote monitoring, and clinical protocols have collectively reduced historical barriers to at-home dialysis, enabling more patients and providers to consider home hemodialysis and peritoneal dialysis as viable long-term care strategies. In this context, stakeholders across clinical, operational, and commercial functions must reframe their understanding of the market as one defined by distributed care pathways rather than facility-centric delivery models.

Transitioning care to the home environment introduces new imperatives for training, supply logistics, and remote clinical oversight. Consequently, manufacturers and service providers are investing in human-centered design, simplified consumables, and intuitive user interfaces that reduce cognitive load for patients and caregivers. At the same time, payers and health systems are re-evaluating reimbursement and outcomes measurement frameworks to align incentives with lower hospitalization rates and improved patient-reported outcomes. Collectively, these dynamics are catalyzing an ecosystem in which technology, policy, and clinical practice converge to widen adoption, improve adherence, and support scalable care models.

How technological advances, supportive payer dynamics, and changing patient preferences are converging to transform home dialysis into a distributed, digitally enabled care model

Recent years have seen transformative shifts in the landscape of home dialysis driven by converging technological, regulatory, and behavioral trends. Telehealth and remote monitoring have moved from niche pilot projects to core components of home dialysis programs, enabling clinicians to maintain clinical oversight while patients remain at home. Concurrently, device manufacturers have prioritized portability, simplified setup workflows, and automated safety checks, making at-home therapy more accessible to a broader patient demographic. These design advances are complemented by improvements in consumables and dialysate management that reduce physical storage burdens and simplify exchanges.

Regulatory frameworks and payer policies are evolving in parallel to support adoption, although variability across jurisdictions continues to shape local uptake. Training models have shifted from prolonged in-center instruction to blended learning approaches that combine in-home coaching with virtual refreshers, which reduces travel burdens and improves retention of skills. Patient preferences have also changed, with greater demand for therapies that accommodate work, family life, and personal autonomy. Taken together, these changes are not incremental; they represent a reorientation of renal care toward distributed, digitally enabled, and patient-centric models that require new value propositions from manufacturers, service providers, and health systems.

Assessment of how tariff shifts in 2025 prompted supply chain reconfiguration, regional sourcing acceleration, and product design changes to protect continuity of care

The introduction of tariff measures in 2025 created immediate attention across global supply chains for medical devices, including components and consumables used in home dialysis systems. Tariffs applied to imported raw materials, finished devices, and specialized consumables have pressured procurement teams to reassess sourcing strategies and supplier portfolios. In response, many stakeholders accelerated nearshoring, diversified supplier bases, and intensified qualification of alternative vendors to mitigate single-source exposure and reduce lead time volatility. These strategic supply chain adaptations have emphasized supplier resilience and quality continuity over lowest-cost sourcing.

Operationally, the tariff landscape prompted manufacturers to re-evaluate product architecture to limit reliance on high-tariff inputs, pursue component standardization, and expand localized assembly where regulatory pathways permitted. Service providers and distributors adjusted contractual terms to share risk and explore inventory buffering strategies while maintaining clinical continuity for patients. Clinicians and health systems signaled a preference for devices and consumables with robust post-market support and predictable supply chains, as interruptions directly impact continuity of care. In summary, the tariff environment served as an accelerant for supply chain redesign, driving investment into regional partnerships, inventory strategies, and design-for-manufacture approaches that prioritize operational resilience and consistent patient access.

Segment-driven insights that connect modality choices, device typologies, distribution pathways, and end-user profiles to investment and commercialization imperatives

A nuanced segmentation of the home dialysis market clarifies where clinical value and commercial opportunity intersect. Based on modality, the market divides into home hemodialysis and peritoneal dialysis, where home hemodialysis is further differentiated by conventional hemodialysis, nocturnal hemodialysis, and short daily hemodialysis, while peritoneal dialysis subdivides into automated peritoneal dialysis and continuous ambulatory peritoneal dialysis. Each modality and sub-modality presents distinct clinical workflows, patient training demands, and device feature priorities, which influence adoption vectors and support models. For example, nocturnal or overnight therapies emphasize device reliability and unobtrusive operation, whereas short daily regimens prioritize rapid setup and minimal caregiver burden.

Based on device type, the market is studied across accessories, consumables, and machines, with the consumables category further segmented into dialysate concentrates and filters. Consumables drive recurring revenue and logistics complexity, and therefore operational efficiency in distribution and supply continuity becomes a critical differentiator. Accessories and machines represent capital and service investments; devices embedded with remote diagnostics reduce lifecycle disruptions and support predictive maintenance. Based on distribution channel, the market is observed through online and retail pathways, which have different implications for patient education, fulfillment logistics, and regulatory compliance. Online channels enable direct-to-patient models and subscription-based replenishment, while retail pathways intersect with traditional medical supply networks and pharmacy partnerships.

Based on end user, the distinction between home healthcare agency and self administration underscores the importance of training, clinical oversight, and service bundles. Home healthcare agencies often require integrated reporting and multi-patient support capabilities, while self-administration models demand highly intuitive user interfaces and strong remote clinical support. Understanding these intersecting segmentation dimensions clarifies where investment in product design, patient education, and distribution infrastructure will yield the greatest clinical and commercial returns.

Regional dynamics and operational realities that determine differentiated adoption pathways and tailored commercialization strategies across major world regions

Regional dynamics influence both the adoption trajectory and the operational models that support home dialysis. In the Americas, clinical practice guidelines, reimbursement policies, and patient advocacy efforts have created concentrated pockets of home therapy adoption, while health system consolidation and digital health investments have supported scaling initiatives. In addition, logistics networks and distribution partnerships in this region emphasize integrated services and value-based contracting, which affect how devices and consumables are bundled and reimbursed.

In Europe, Middle East & Africa, fragmentation across regulatory regimes and payer structures creates a heterogeneous adoption landscape. Some countries have advanced national strategies that actively promote home therapy, while others face infrastructural constraints that limit widespread implementation. Market entrants therefore prioritize adaptable business models, local partnerships, and tailored training programs to bridge capability gaps. The Asia-Pacific region presents a combination of rapid innovation adoption in urban centers and infrastructure challenges in rural areas, prompting hybrid deployment strategies that combine pharmacy and retail networks with telehealth-enabled clinical support. Supply chain considerations, regional manufacturing hubs, and regulatory timelines further differentiate go-to-market approaches across these geographies. Taken together, regional insights underscore that scalable solutions must be adaptable to local clinical practices, reimbursement models, and supply chain realities to achieve sustainable uptake.

Competitive positioning analysis highlighting how incumbents, specialized suppliers, and digital entrants are reshaping value propositions through integrated clinical and service capabilities

Competitive dynamics in the home dialysis space are shaped by a mix of legacy medical device companies, specialized consumable suppliers, and digitally native entrants focused on software-enabled care. Incumbent device manufacturers maintain advantages in regulatory experience, clinical evidence generation, and established distribution, which support large-scale procurement relationships. At the same time, newer entrants often differentiate through design simplicity, innovative consumables, and integrated remote monitoring capabilities that appeal to patient-centric programs.

Partnerships between device makers and digital health providers are increasingly common, combining hardware with cloud-based platforms for remote monitoring, adherence tracking, and teleconsultation. Distribution partners and home healthcare agencies also play an important role in shaping adoption through training, service delivery, and inventory management. Competitive advantage increasingly depends on the ability to offer an end-to-end value proposition that addresses clinical outcomes, operational resilience, and total cost of care rather than focusing solely on unit-level device performance. As a result, companies that align product development with service models, robust supply chains, and payer engagement strategies are better positioned to capture the shifting demand toward home-based renal therapies.

Actionable strategic initiatives for industry leaders to simplify patient workflows, strengthen supply chains, and integrate digital care to scale home dialysis programs

Industry leaders should prioritize a set of actionable initiatives to capture value in an evolving home dialysis ecosystem. First, invest in product designs that simplify patient workflows and minimize consumable handling, thereby lowering the barrier to self administration and improving adherence. Second, accelerate digital integration by building remote monitoring, predictive maintenance, and care coordination features that reduce clinician burden and enable outcomes-based contracting. Third, diversify and de-risk supply chains by qualifying regional suppliers, increasing component modularity, and exploring localized assembly options to maintain continuity of care in the face of trade disruptions.

Moreover, commercial teams should develop hybrid go-to-market models that combine online fulfillment with retail and home healthcare partnerships to meet varied patient access patterns. Training and support must be reframed as a core service offering, embedding blended learning and competency assessments to ensure safe self administration. Finally, engage proactively with payer stakeholders to demonstrate the value of home modalities through real-world evidence and patient-reported outcomes, thereby aligning reimbursement with long-term clinical benefit. Taken together, these recommendations provide a pragmatic blueprint for organizations seeking to scale home dialysis programs while managing operational risk and delivering measurable clinical value.

Methodological approach combining stakeholder interviews, clinical literature synthesis, and supply chain analysis to deliver validated, actionable insights on home dialysis systems

The research methodology underpinning this analysis triangulates primary stakeholder interviews, device and clinical literature review, regulatory analysis, and supply chain mapping to produce an integrated perspective on home dialysis systems. Primary interviews were conducted with clinicians, supply chain leads, and commercial executives to surface operational constraints, adoption drivers, and unmet needs. These qualitative insights were complemented by a systematic review of device design trends, consumable innovations, and published clinical protocols to ensure technical accuracy and relevance.

Supply chain analysis included component sourcing, logistics pathways, and tariff impacts to elucidate operational levers and risk exposures. Additionally, payer and reimbursement frameworks were examined to understand incentives and barriers to adoption across major regions. The methodological approach emphasizes transparency in assumptions and traceability of insights, enabling stakeholders to adapt findings to their organizational context. Where applicable, sensitivity checks and validation conversations with independent experts were used to corroborate key themes and ensure the analysis reflects current industry practice and emerging developments.

Synthesis of key strategic imperatives that align device innovation, clinical support, and supply chain resilience to advance sustainable home dialysis adoption

In conclusion, the home dialysis landscape is at an inflection point where clinical advances, patient preferences, and operational redesign converge to create durable opportunities for improved care delivery. The shift toward home-based therapies requires integrated solutions that marry device innovation with training, supply chain reliability, and payer engagement. While trade dynamics and regional variability necessitate differentiated strategies, the underlying trend toward patient-centered, digitally enabled care remains consistent across geographies.

Organizations that respond by simplifying user experience, investing in remote clinical capabilities, and strengthening supply chain resilience will be best positioned to deliver sustained clinical and commercial value. Collaboration across manufacturers, payers, providers, and distributors will be essential to unlock the full potential of home dialysis as a mainstream care pathway. As stakeholders refine their strategies, ongoing evidence generation and adaptive operational models will provide the foundation for safe, scalable, and patient-preferred renal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Dialysis Systems Market, by Modality

  • 8.1. Home Hemodialysis
    • 8.1.1. Conventional Hemodialysis
    • 8.1.2. Nocturnal Hemodialysis
    • 8.1.3. Short Daily Hemodialysis
  • 8.2. Peritoneal Dialysis
    • 8.2.1. Automated Peritoneal Dialysis
    • 8.2.2. Continuous Ambulatory Peritoneal Dialysis

9. Home Dialysis Systems Market, by Device Type

  • 9.1. Accessories
  • 9.2. Consumables
    • 9.2.1. Dialysate Concentrates
    • 9.2.2. Filters
  • 9.3. Machines

10. Home Dialysis Systems Market, by End User

  • 10.1. Home Healthcare Agency
  • 10.2. Self Administration

11. Home Dialysis Systems Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Retail

12. Home Dialysis Systems Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Home Dialysis Systems Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Home Dialysis Systems Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Home Dialysis Systems Market

16. China Home Dialysis Systems Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Allmed Medical Care Holdings Limited
  • 17.6. AWAK Technologies Pte. Ltd.
  • 17.7. B. Braun Avitum AG
  • 17.8. Bain Medical Equipment Co., Ltd.
  • 17.9. Baxter International Inc.
  • 17.10. DaVita Inc.
  • 17.11. Fresenius Medical Care AG & Co. KGaA
  • 17.12. Infomed SA
  • 17.13. Jiangsu Jihua Medical Instruments Co., Ltd.
  • 17.14. JMS Co., Ltd.
  • 17.15. Kawasaki Laboratories, Inc.
  • 17.16. Medica SpA
  • 17.17. Medical Components, Inc.
  • 17.18. Medtronic plc
  • 17.19. Nikkiso Co., Ltd.
  • 17.20. Nipro Corporation
  • 17.21. Outset Medical, Inc.
  • 17.22. Quanta Dialysis Technologies Ltd.
  • 17.23. Rockwell Medical, Inc.
  • 17.24. SWS Hemodialysis Care
  • 17.25. Toray Medical Co., Ltd.
  • 17.26. Weigao Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME DIALYSIS SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME DIALYSIS SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY NOCTURNAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY NOCTURNAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY NOCTURNAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SHORT DAILY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SHORT DAILY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SHORT DAILY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE CONCENTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE CONCENTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE CONCENTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEALTHCARE AGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEALTHCARE AGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEALTHCARE AGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 134. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 135. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 137. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 157. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 159. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 166. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 167. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 169. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)